Cerus (STU:CU2) Non Operating Income : €-2.1 Mil (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Cerus Non Operating Income?

Non Operating Income is income or expense that comes from miscellaneous sources. Cerus's Non Operating Income for the three months ended in Mar. 2024 was €0.5 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.1 Mil.

Cerus Non Operating Income Historical Data

The historical data trend for Cerus's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cerus Non Operating Income Chart

Cerus Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Non Operating Income

Get a 7-Day Free Trial

1.18

2.06

-0.18

-2.29

-2.39

Cerus Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Non Operating Income	Get a 7-Day Free Trial															0.18	-1.42	-1.13	-0.06	0.55

Cerus Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.1 Mil.

Cerus Non Operating Income Related Terms

Thank you for viewing the detailed overview of Cerus's Non Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Cerus (STU:CU2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cerus Corp (STU:CU2) » Definitions » Non Operating Income

Comparable Companies

Traded in Other Exchanges

CERS:USA

Address

1220 Concord Avenue, Suite 600, Concord, CA, USA, 94520

Website

http://www.cerus.com

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Cerus (STU:CU2) Headlines

No Headlines